Company Filing History:
Years Active: 1993
Title: Hiroshi Shiraki: Innovator in Peptide Technology
Introduction
Hiroshi Shiraki is a notable inventor based in Onojo, Japan, recognized for his contributions to the field of peptide technology. With a solid background in research and development, Shiraki has secured a patent that showcases his innovative approach to addressing medical challenges.
Latest Patents
Shiraki holds a patent for "Anti-ATLA antibody binding peptides," which includes a peptide of the general formula designed to enhance binding characteristics to antibody targets. This invention is significant in the field of therapeutic development and presents potential for advancements in medical treatments.
Career Highlights
Hiroshi Shiraki has built his career at Kuraray Co., Ltd., where he has utilized his expertise in biochemistry and molecular biology. His work has not only contributed to the company’s research capabilities but has also placed him at the forefront of peptide innovation.
Collaborations
Shiraki collaborates with esteemed colleagues such as Yoshiaki Maeda and Yukiko Washitani, with whom he shares insights and advances in their respective fields. These collaborations are vital for fostering innovation and bringing new inventions to fruition.
Conclusion
Hiroshi Shiraki's contributions to peptide technology through his patented inventions exemplify the spirit of innovation present in today's research landscape. As he continues to work with Kuraray Co., Ltd. and engage with accomplished colleagues, his future endeavors are anticipated to further impact the medical field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.